Morning Digest | Anger rages against Agnipath in many States; China foils bid to designate Lashkar deputy chief a terrorist; India backs China’s plan for joint border activity, and more
The Hindu
A select list of stories to read before you start your day
Anger rages against Agnipath in many States
Man killed as police open fire to stop protesters in Secunderabad; hundreds injured, scores arrested as agitation turns violent at several places; trains and public property damaged; Railways says over 340 trains affected.
India backs China’s plan for joint border activity
India has supported an initiative by China to conduct a “joint border operation” in 2023 of all member countries of SCO (Shanghai Cooperation Organisation) that includes Russia, Pakistan and Central Asian countries. The border operation called “Solidarity-2023” will be organised by China, a statement by the Border Security Force (BSF) said.
Covaxin demonstrates robust safety and immunogenicity in children 2-18 years: Bharat Biotech
Bharat Biotech International Limited (BBIL), on Friday, announced that COVID-19 vaccine Covaxin (BBV152) has proven to be safe, well-tolerated, and highly immunogenic in paediatric subjects in phase II/III study. The study, according to the company, has been accepted and published in Lancet Infectious diseases.
Pakistan may get off terror funding watchdog’s ‘grey list’ after on-site check